Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: Data from the Valsartan heart failure trial (Val-HeFT)

Serge Masson, Scott Solomon, Laura Angelici, Roberto Latini, Inder S. Anand, Margaret Prescott, Aldo P. Maggioni, Gianni Tognoni, Jay N. Cohn

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: Data from the Valsartan heart failure trial (Val-HeFT)'. Together they form a unique fingerprint.

Medicine & Life Sciences